연구성과로 돌아가기
JCR 2023 저널 목록 (1484 / 2065)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MEDICAL LETTER ON DRUGS AND THERAPEUTICS | MED LETTER INC | 0025-732X | 1523-2859 | SCIE | PHARMACOLOGY & PHARMACY | 450 | 1.4 | Q4 | 77.5 | 22.5 | 275/354 | 1.1 | Q4 | 0.8 | 1.3 | 0.28 | 299/354 | Q4 | 15.68 | 0.000 | 0.082 | 0.175 | Q4 | 54 | 100.0% | 3.1 | 3.2 | 54 | 0.0% | 2025-03-24 17:36:45 | 바로가기 |
| Nephrology Nursing Journal | JANNETTI PUBLICATIONS, INC | 1526-744X | 2163-5390 | SCIE, SSCI | NURSING | 500 | 0.8 | Q4 | 77.5 | 22.5 | 150/193 | 0.9 | Q4 | 0.6 | 0.1 | 0.29 | 169/193 | Q4 | 12.69 | 0.000 | 0.063 | 0.193 | Q4 | 36 | 88.9% | 9.3 | 6.5 | 32 | 0.0% | 2025-03-24 17:32:53 | 바로가기 |
| Nursing and Midwifery Studies | KASHAN UNIV MEDICAL SCIENCES | 2322-1488 | 2322-1674 | ESCI | NURSING | 407 | 0.8 | Q4 | 77.5 | 22.5 | 150/193 | 1.0 | Q4 | 0.7 | 0.1 | 0.42 | 147/193 | Q4 | 24.09 | 0.000 | 0.064 | 0.200 | Q4 | 36 | 100.0% | 6.6 | 5.0 | 36 | 27.2% | 2025-03-24 17:32:54 | 바로가기 |
| Nursing-Research and Reviews | DOVE MEDICAL PRESS LTD | 2230-522X | 2230-522X | ESCI | NURSING | 95 | 0.8 | Q4 | 77.5 | 22.5 | 150/193 | 1.2 | Q3 | 0.8 | <0.1 | 0.58 | 118/193 | Q3 | 39.12 | 0.000 | 0.017 | 0.253 | Q4 | 7 | 85.7% | N/A | 6.0 | 6 | 100.0% | 2025-03-24 17:32:57 | 바로가기 |
| Orthopaedic Nursing | LIPPINCOTT WILLIAMS & WILKINS | 0744-6020 | 1542-538X | SCIE, SSCI | NURSING | 672 | 0.8 | Q4 | 77.5 | 22.5 | 150/193 | 1.0 | Q4 | 0.7 | <0.1 | 0.35 | 160/193 | Q4 | 17.36 | 0.000 | 0.098 | 0.263 | Q4 | 35 | 88.6% | 9.1 | 6.9 | 31 | 7.6% | 2025-03-24 17:32:52 | 바로가기 |
| Pflege | HOGREFE AG-HOGREFE AG SUISSE | 1012-5302 | 1664-283X | SCIE, SSCI | NURSING | 247 | 0.8 | Q4 | 77.5 | 22.5 | 150/193 | 0.8 | Q4 | 0.6 | 0.1 | 0.43 | 145/193 | Q4 | 25.13 | 0.000 | 0.054 | 0.162 | Q4 | 40 | 95.0% | 4.9 | 6.2 | 38 | 12.0% | 2025-03-24 17:32:56 | 바로가기 |
| Pharmaceutical Sciences | TABRIZ UNIV MEDICAL SCIENCES, FAC PHARMACY | 1735-403X | 2383-2886 | ESCI | PHARMACOLOGY & PHARMACY | 584 | 1.4 | Q4 | 77.5 | 22.5 | 275/354 | 1.2 | Q4 | 1.3 | 0.5 | 0.47 | 251/354 | Q3 | 29.24 | 0.000 | 0.085 | 0.164 | Q4 | 48 | 77.1% | 4.6 | 8.1 | 37 | 92.1% | 2025-03-24 17:36:43 | 바로가기 |
| Research and Theory for Nursing Practice | SPRINGER PUBLISHING CO | 1541-6577 | 1945-7286 | SCIE, SSCI | NURSING | 411 | 0.8 | Q4 | 77.5 | 22.5 | 150/193 | 0.9 | Q4 | 0.7 | <0.1 | 0.35 | 160/193 | Q4 | 17.36 | 0.000 | 0.042 | 0.196 | Q4 | 25 | 92.0% | 10.6 | 5.9 | 23 | 0.0% | 2025-03-24 17:32:54 | 바로가기 |
| Reviews on Recent Clinical Trials | BENTHAM SCIENCE PUBL LTD | 1574-8871 | 1876-1038 | ESCI | PHARMACOLOGY & PHARMACY | 592 | 1.4 | Q4 | 77.5 | 22.5 | 275/354 | 1.5 | Q4 | 1.3 | 0.5 | 0.36 | 280/354 | Q4 | 21.05 | 0.001 | 0.123 | 0.346 | Q4 | 34 | 67.6% | 5.9 | 6.8 | 23 | 2.4% | 2025-03-24 17:36:43 | 바로가기 |
| Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy | SPRINGERNATURE | 0102-695X | 1981-528X | SCIE | PHARMACOLOGY & PHARMACY | 3,403 | 1.4 | Q4 | 77.5 | 22.5 | 275/354 | 1.9 | Q3 | 1.3 | 0.4 | 0.34 | 286/354 | Q4 | 19.35 | 0.001 | 0.247 | 0.253 | Q4 | 149 | 80.5% | 8.2 | 6.9 | 120 | 9.3% | 2025-03-24 17:36:27 | 바로가기 |
| STEROIDS | ELSEVIER SCIENCE INC | 0039-128X | 1878-5867 | SCIE | BIOCHEMISTRY & MOLECULAR BIOLOGY | 5,896 | 2.1 | Q4 | 77.5 | 22.5 | 243/313 | 2.4 | Q4 | 1.9 | 0.9 | 0.52 | 223/313 | Q3 | 28.91 | 0.002 | 0.509 | 0.430 | Q4 | 100 | 88.0% | 9.8 | 9.9 | 88 | 8.8% | 2025-03-24 16:55:45 | 바로가기 |
| Applied Economics Journal | KASERSART UNIV, FAC ECONOMICS | 2586-9124 | 2586-9132 | ESCI | ECONOMICS | 45 | 0.6 | Q4 | 77.6 | 22.4 | 466/600 | 0.6 | Q4 | 0.6 | <0.1 | 0.22 | 473/603 | Q4 | 21.64 | 0.000 | 0.009 | 0.085 | Q4 | 8 | 100.0% | N/A | 14.7 | 8 | 0.0% | 2025-03-24 17:05:40 | 바로가기 |
| Argumenta Oeconomica | WROCLAW UNIV ECONOMICS | 1233-5835 | 2720-5088 | SSCI | ECONOMICS | 119 | 0.6 | Q4 | 77.6 | 22.4 | 466/600 | 0.4 | Q4 | 0.5 | 0.1 | 0.20 | 483/603 | Q4 | 19.98 | 0.000 | 0.019 | 0.075 | Q4 | 25 | 100.0% | 6.0 | 10.5 | 25 | 100.0% | 2025-03-24 17:05:34 | 바로가기 |
| Clinical and Experimental Vaccine Research | KOREAN VACCINE SOC | 2287-3651 | 2287-366X | ESCI | IMMUNOLOGY | 516 | 2.1 | Q4 | 77.6 | 22.4 | 141/181 | 1.8 | Q4 | 2.0 | 0.3 | 0.42 | 140/181 | Q4 | 22.93 | 0.000 | 0.093 | 0.395 | Q4 | 37 | 78.4% | 6.2 | 3.3 | 29 | 100.0% | 2025-03-24 17:20:25 | 바로가기 |
| Convergencia-Revista de Ciencias Sociales | UNIV AUTONOMA ESTADO MEXICO | 2448-5799 | 2448-5799 | SSCI | SOCIOLOGY | 230 | 0.5 | Q4 | 77.6 | 22.4 | 169/217 | 0.7 | Q4 | 0.5 | 0.2 | 0.26 | 172/217 | Q4 | 20.97 | 0.000 | 0.063 | 0.342 | Q3 | 13 | 100.0% | 8.2 | 7.0 | 13 | 94.7% | 2025-03-24 18:11:40 | 바로가기 |
페이지 이동: